RankAlpha logo
Back to Rankings

IMTX

ImmaticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
IMTX vs peer average
61/100
IMTX vs. peer average (B vs. C)
Grade spread
A 1 · B 4 · C 3 · D 1 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

BMY is the first available peer comparator.

Bristol-Myers Squibb — major oncology/ cell-therapy investor with pipeline M&A history; benchmark for strategic exit scenarios.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBMYBristol-Myers Squibb
IMTX
Immatics
BMY
Bristol-Myers Squibb
Grade
B
C
Momentum
73
43
Value
43
70
Sentiment
69
51
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs BMY

IMTX / BMY
Grade Position
In line
IMTX vs. peer average (B vs. C)
61/100
Momentum
73
IMTX
Value
43
BMY
Sentiment
69
IMTX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IMTX
1
BMY
BMY
B
80/100
Even
2
GILD
GILD
B
80/100
Even
3
IOVA
IOVA
B
80/100
Even
4
PGEN
Precigen Inc Common
C
60/100
+1
5
DMRA
Damora Therapeutics Inc Common
C
60/100
+1
BMY is the first peer returned for this comparison set.